MAM
JAZZ icon

Martingale Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Martingale Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.83M Buy
+46,721
New +$8.17M 0.22% 119
2025
Q4 		– Sell
-2,360
Closed -$311K – 807
2025
Q3 		$311K Sell
2,360
-147
-6% -$17.6K 0.01% 691
2025
Q2 		$266K Sell
2,507
-6,134
-71% -$666K 0.01% 721
2025
Q1 		$1.07M Buy
8,641
+4,656
+117% +$607K 0.03% 439
2024
Q4 		$491K Sell
3,985
-1,584
-28% -$187K 0.01% 608
2024
Q3 		$620K Buy
5,569
+3,650
+190% +$400K 0.01% 583
2024
Q2 		$205K Sell
1,919
-4,514
-70% -$496K ﹤0.01% 759
2024
Q1 		$775K Sell
6,433
-294
-4% -$36K 0.02% 525
2023
Q4 		$827K Sell
6,727
-55,114
-89% -$6.88M 0.02% 491
2023
Q3 		$8M Sell
61,841
-18,267
-23% -$2.43M 0.17% 140
2023
Q2 		$9.93M Sell
80,108
-17,429
-18% -$2.34M 0.19% 136
2023
Q1 		$14.3M Sell
97,537
-4,508
-4% -$667K 0.28% 129
2022
Q4 		$16.3M Buy
102,045
+11,557
+13% +$1.69M 0.32% 124
2022
Q3 		$12.1M Buy
90,488
+38,828
+75% +$5.9M 0.24% 133
2022
Q2 		$8.06M Buy
51,660
+50,136
+3,290% +$7.72M 0.15% 155
2022
Q1 		$238K Buy
+1,524
New +$221K ﹤0.01% 771
2021
Q3 		– Sell
-181,625
Closed -$32.3M – 892
2021
Q2 		$32.3M Sell
181,625
-23,617
-12% -$4.09M 0.37% 103
2021
Q1 		$33.7M Sell
205,242
-57,526
-22% -$9.47M 0.39% 98
2020
Q4 		$43.4M Sell
262,768
-24,772
-9% -$3.69M 0.49% 74
2020
Q3 		$41M Sell
287,540
-32,752
-10% -$4.06M 0.49% 63
2020
Q2 		$35.3M Sell
320,292
-3,027
-0.9% -$335K 0.42% 70
2020
Q1 		$32.2M Sell
323,319
-29,520
-8% -$3.82M 0.43% 65
2019
Q4 		$52.7M Sell
352,839
-28,215
-7% -$3.84M 0.54% 42
2019
Q3 		$48.8M Buy
381,054
+39,757
+12% +$5.33M 0.5% 52
2019
Q2 		$48.7M Buy
341,297
+20,421
+6% +$2.74M 0.51% 49
2019
Q1 		$45.9M Buy
320,876
+79,521
+33% +$10.4M 0.5% 50
2018
Q4 		$29.9M Buy
241,355
+66,839
+38% +$9.92M 0.4% 91
2018
Q3 		$29.3M Buy
174,516
+172,913
+10,787% +$29.7M 0.34% 105
2018
Q2 		$277K Buy
+1,603
New +$262K ﹤0.01% 931
2016
Q3 		– Sell
-26,355
Closed -$3.73M – 970
2016
Q2 		$3.73M Sell
26,355
-51,162
-66% -$7.54M 0.06% 258
2016
Q1 		$10.1M Buy
77,517
+16,150
+26% +$2.01M 0.2% 170
2015
Q4 		$8.63M Sell
61,367
-7,595
-11% -$1.05M 0.19% 175
2015
Q3 		$9.16M Buy
68,962
+11,706
+20% +$2.02M 0.22% 153
2015
Q2 		$10.1M Buy
57,256
+35,804
+167% +$6.43M 0.24% 138
2015
Q1 		$3.71M Buy
21,452
+6,100
+40% +$1.05M 0.09% 244
2014
Q4 		$2.51M Buy
+15,352
New +$2.55M 0.07% 281

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Martingale Asset Management's JAZZ Position: Q1 2026 in Review

Martingale Asset Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 46,721 shares worth $8.83M. The stake represents 0.22% of the portfolio and ranks #119 among its holdings. This is a return to the name: Martingale Asset Management previously reported a position in JAZZ as recently as Q3 2025.

Martingale Asset Management first reported a position in JAZZ in Q4 2014 and has held it in 36 quarters since. The position peaked at $52.7M in Q4 2019. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Martingale Asset Management held 46,721 shares of Jazz Pharmaceuticals worth $8.83M as of Q1 2026.
  • Jazz Pharmaceuticals was a new Martingale Asset Management position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.22% of Martingale Asset Management's portfolio in Q1 2026, its #119 holding.
  • Martingale Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 36 quarters since.
  • Martingale Asset Management's Jazz Pharmaceuticals position peaked at $52.7M in Q4 2019.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.